Literature DB >> 28934420

Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.

Katherine W Kooij1, Liffert Vogt2, Ferdinand W N M Wit1,3,4, Marc van der Valk3, Rosan A van Zoest1, Abraham Goorhuis3, Maria Prins3,5, Frank A Post6, Peter Reiss1,3,4.   

Abstract

Background: Human immunodeficiency virus (HIV)-infected individuals are at increased risk of chronic kidney disease (CKD). Human immunodeficiency virus infection, traditional CKD risk factors, and combination antiretroviral therapy (cART) may all contribute.
Methods: We compared prevalence of renal impairment (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73m2), albuminuria (albumin/creatinine ratio ≥3 mg/mmol), and proximal renal tubular dysfunction (retinol-binding protein/creatinine ratio >2.93μg/mmol and/or fractional phosphate excretion >20% with plasma phosphate <0.8 mmol/L) in 596 HIV-infected and 544 HIV-uninfected AGEhIV Cohort Study participants. We also assessed whether being HIV-infected on cART, with follow-up censored when cART regimen was modified, was associated with greater eGFR decline or worsening albuminuria (increase ≥10%/year with change in albuminuria category).
Results: Human immunodeficiency virus infection was independently associated with renal impairment (adjusted odds ratio [aOR] = 2.1; 95% confidence interval [CI] = 1.0-4.4), albuminuria (aOR = 5.8; 95% CI = 3.7-9.0), and proximal renal tubular dysfunction (aOR = 7.0; 95% CI = 4.9-10.2]). Among 377 HIV-infected and 479 HIV-uninfected individuals (median follow-up = 3.9/4.1 years, respectively) included in longitudinal analyses, being HIV-infected and remaining on unmodified cART was independently associated with greater eGFR decline (-0.56; 95% CI = -0.87 to -0.24 mL/min/1.73m2/year) and worsening albuminuria (aOR = 2.3; 95% CI = 1.3-4.0). Conclusions: In these middle-aged individuals, HIV infection was independently associated with renal impairment, albuminuria, and proximal renal tubular dysfunction. Human immunodeficiency virus-infected individuals on cART (predominantly containing tenofovir disoproxil fumarate) were also more likely to experience eGFR decline and worsening albuminuria compared with HIV-uninfected individuals.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV infection; albuminuria; proximal renal tubular dysfunction; renal impairment; tenofovir disoproxil fumarate

Mesh:

Substances:

Year:  2017        PMID: 28934420     DOI: 10.1093/infdis/jix202

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Chronic Kidney Disease in the Aging Human Immunodeficiency Virus-Infected Population.

Authors:  Jeffrey B Kopp
Journal:  J Infect Dis       Date:  2017-09-15       Impact factor: 5.226

Review 2.  HIV and Aging in Mainland China: Implications for Control and Prevention Research.

Authors:  Na He; Yingying Ding; Jing Li; Shiying Yuan; Lulu Xu; Shijie Qiao; Xiaohui Xu; Bowen Zhu; Ruizi Shi; John P Barile; Frank Y Wong
Journal:  Curr HIV/AIDS Rep       Date:  2019-12       Impact factor: 5.071

3.  Prevalence of Chronic Kidney Disease and Poor Diagnostic Accuracy of Dipstick Proteinuria in Human Immunodeficiency Virus-Infected Individuals: A Multicenter Study in Japan.

Authors:  Naoki Yanagisawa; Takashi Muramatsu; Tomohiko Koibuchi; Akihiro Inui; Yusuke Ainoda; Toshio Naito; Kosaku Nitta; Atsushi Ajisawa; Katsuyuki Fukutake; Aikichi Iwamoto; Minoru Ando
Journal:  Open Forum Infect Dis       Date:  2018-09-05       Impact factor: 3.835

4.  Renal dysfunction among adult HIV/AIDS patients on antiretroviral therapy at a tertiary facility in Ghana.

Authors:  Dorcas Obiri-Yeboah; Yaw Asante Awuku; Wonderful Alofa; Alice Charwudzi; Ebenezer Aniakwa-Bonsu; Evans Obboh; Paul Nsiah
Journal:  BMC Nephrol       Date:  2018-11-21       Impact factor: 2.388

5.  Systematic De-escalation of Successful Triple Antiretroviral Therapy to Dual Therapy with Dolutegravir plus Emtricitabine or Lamivudine in Swiss HIV-positive Persons.

Authors:  Natascha D Diaco; Claudio Strickler; Stéphanie Giezendanner; Sebastian A Wirz; Philip E Tarr
Journal:  EClinicalMedicine       Date:  2018-12-06

6.  Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA.

Authors:  A M Mills; K L Schulman; J S Fusco; L Brunet; R Hsu; A Beyer; G Prajapati; K Mounzer; G P Fusco
Journal:  HIV Med       Date:  2020-01-27       Impact factor: 3.180

Review 7.  The challenge of HIV treatment in an era of polypharmacy.

Authors:  David Back; Catia Marzolini
Journal:  J Int AIDS Soc       Date:  2020-02       Impact factor: 5.396

8.  Incidence and predictors of tenofovir disoproxil fumarate-induced renal impairment in HIV infected Nigerian patients.

Authors:  Bazim V Ojeh; Isaac O Abah; Placid Ugoagwu; Patricia A Agaba; Oche O Agbaji; Steven S Gyang
Journal:  Germs       Date:  2018-06-04

9.  Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy.

Authors:  Leonardo Calza; Michele Sachs; Vincenzo Colangeli; Marco Borderi; Bianca Granozzi; Pietro Malosso; Giorgia Comai; Valeria Corradetti; Gaetano La Manna; Pierluigi Viale
Journal:  Clin Exp Nephrol       Date:  2019-07-20       Impact factor: 2.801

10.  Correlation between CD4 count and glomerular filtration rate or urine protein:creatinine ratio in human immunodeficiency virus-infected children.

Authors:  Almira Aliyannissa; Rahmat Budi Kuswiyanto; Djatnika Setiabudi; Heda Melinda Nataprawira; Anggraini Alam; Nanan Sekarwana
Journal:  Kidney Res Clin Pract       Date:  2020-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.